XML 58 R34.htm IDEA: XBRL DOCUMENT v3.25.2

Reverse Takeover Transaction with NCAC (Tables)

12 Months Ended

Mar. 31, 2025

Reverse Takeover Transaction with NCAC [Abstract]

Schedule of Listing Expenses

The calculation of listing expenses is as follows:

		Listing Expense
Consideration paid:
Shares issued to NCAC shareholders			13,040
Total consideration shares issued			13,040
Fair value of the common shares		$	2,863.22
Deemed consideration amount for the common shares issued		$	37,336,416
Net identifiable liabilities acquired:
Cash and cash equivalent		$	203
Accounts payable and accrued liabilities		$	(2,136,505	)
NCAC promissory note (Note 11)		$	(1,413,529	)
Derivative warrant liabilities (Note 10)		$	(595,358	)
Net liabilities acquired		$	4,145,189
Listing expense		$	41,481,605

X

- References

No definition available.

+ Details

Name:	pbm_ReverseTakeoverTransactionWithNcacAbstract
Namespace Prefix:	pbm_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The tabular disclosure of calculation of listing expenses.

+ References

No definition available.

+ Details

Name:	pbm_ScheduleOfListingExpensesTableTextBlock
Namespace Prefix:	pbm_
Data Type:	dtr:textBlockItemType
Balance Type:	na
Period Type:	duration